Studies
Submitter: René Hänsel
Investigation: HighCHOEP phase 2
Resources: No Resources
Study type: Not specified
Mega-CHOEP phase III is a randomised study comparing conventional chemoimmunotherapy with R-CHOEP-14 with high-dose chemotherapy plus Rituximab with autologous stem cell transplantation in high-risk patients aged 61 to 80 years with Aggressive Non-Hodgkin’s Lymphoma.
Submitter: René Hänsel
Investigation: MegaCHOEP Phase III
Resources: No Resources
Study type: Not specified
Baseline Data and Endpoints for MAXSEP
Submitter: René Hänsel
Investigation: MAXSEP
Resources: MAXSEP Trial Data, MAXSEP Trial Metadata
Study type: Not specified
Baseline Data and Endpoints for SISPCT
Submitter: René Hänsel
Investigation: SISPCT
Resources: SISPCT Trail Data, SISPCT Trail Metadata
Study type: Not specified
